Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results
Announced acceptance and Priority Review by the United States Food and Drug Administration (FDA) of the new drug application (NDA) for troriluzole in all-genotype... Read more.
Peerbridge Health Unveils Cor MDx™ Next-Generation IoT ECG Wearable at HIMSS Global Health Conference
Wireless connectivity enablement with AT&T helps Peerbridge expand access to AI-driven cardiac care LAS VEGAS, March 3, 2025 /PRNewswire/ — Peerbridge... Read more.
Fiserv Completes Acquisition of Payfare
TORONTO, March 3, 2025 /PRNewswire/ – Payfare Inc. (“Payfare” or the “Company“) (TSX: PAY) (OTCQX: PYFRF) today announced that 1517452... Read more.
Odine to Provide Advanced Cloud-Based Provisioning for Turkcell
ISTANBUL, March 3, 2025 /PRNewswire/ — Odine (BIST: ODINE), a global technology partner, has worked with Mavenir to empower Turkcell (NYSE: TKC) (BIST: TCELL)... Read more.
AB Token Now Live on Bitget, with a $3.5 Million Airdrop to Boost Global Ecosystem Expansion
SINGAPORE, March 3, 2025 /PRNewswire/ — AB DAO announced that $AB has been officially listed on Bitget (bitget.com) in the Innovation Zone and Web3 Zone, further... Read more.
Top Global Biopharmas Standardize on Veeva China CRM Suite
6 of the top 20 biopharmas have chosen Veeva for China-specific CRM PLEASANTON, Calif. and SHANGHAI, March 3, 2025 /PRNewswire/ — Veeva Systems (NYSE: VEEV)... Read more.
AlphaGraphics earns nearly $330 million nationwide in 2024
The leading franchisor of printing and marketing solutions awarded 22 new franchise agreements over the course of the last year DENVER, March 3, 2025 /PRNewswire/... Read more.
Alexis Ohanian, Renowned Internet Entrepreneur and Co-Founder of Reddit, Joins Project Liberty and The People’s Bid for TikTok
NEW YORK, March 3, 2025 /PRNewswire/ — American technology entrepreneur and venture capitalist Alexis Ohanian announced today that he will join The People’s... Read more.
Quad Completes Sale of its European Operations to Capmont
SUSSEX, Wis., March 3, 2025 /PRNewswire/ — Quad/Graphics, Inc. (NYSE: QUAD) (“Quad” or the “Company”), a marketing experience (MX)... Read more.
QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause
QALSODY targets the root cause of SOD1-ALS, an ultra-rare and uniformly fatal neurodegenerative disease marked by motor neuron loss in the brain and spinal cord1... Read more.